Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India
- PMID: 17382981
- DOI: 10.1016/j.trstmh.2007.02.008
Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India
Abstract
Although visceral leishmaniasis (VL) is endemic in various parts of India, mainly Bihar, West Bengal and Orissa, and neighbouring countries such as Nepal and Bangladesh, it is rarely reported from the hilly areas of India. We report on nine male VL cases from the non-endemic Garhwal region of Uttarakhand who were treated successfully with sodium stibogluconate. We conclude that sodium stibogluconate-sensitive VL is emerging in this region and that urgent and effective vector control measures may be warranted to prevent the disease from becoming a major health problem and to ensure that resistance to sodium stibogluconate does not emerge.
Similar articles
-
Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.Natl Med J India. 2005 May-Jun;18(3):131-3. Natl Med J India. 2005. PMID: 16130613
-
Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.Clin Infect Dis. 2000 Oct;31(4):1104-7. doi: 10.1086/318121. Clin Infect Dis. 2000. PMID: 11049798 Clinical Trial.
-
Changing Epidemiology: A New Focus of Kala-azar at High-Altitude Garhwal Region of North India.J Trop Pediatr. 2017 Apr 1;63(2):104-108. doi: 10.1093/tropej/fmw056. J Trop Pediatr. 2017. PMID: 27582128
-
Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.J Assoc Physicians India. 2003 Jul;51:686-90. J Assoc Physicians India. 2003. PMID: 14621038 Review.
-
Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and Sudan.Drug Dev Ind Pharm. 2010 Nov;36(11):1312-9. doi: 10.3109/03639041003796648. Drug Dev Ind Pharm. 2010. PMID: 20545513 Review.
Cited by
-
Climate change and threat of vector-borne diseases in India: are we prepared?Parasitol Res. 2010 Mar;106(4):763-73. doi: 10.1007/s00436-010-1767-4. Epub 2010 Feb 13. Parasitol Res. 2010. PMID: 20155369 Review.
-
Role of Haematological Changes in Predicting Occurrence of Leishmaniasis- A Study in Kumaon Region of Uttarakhand.J Clin Diagn Res. 2016 May;10(5):EC39-43. doi: 10.7860/JCDR/2016/15438.7885. Epub 2016 May 1. J Clin Diagn Res. 2016. PMID: 27437230 Free PMC article.
-
Evidence for involvement of TNFR1 and TIMPs in pathogenesis of post-kala-azar dermal leishmaniasis.Clin Exp Immunol. 2008 Dec;154(3):391-8. doi: 10.1111/j.1365-2249.2008.03761.x. Clin Exp Immunol. 2008. PMID: 19037922 Free PMC article.
-
Rising visceral leishmaniasis in Holy Himalayas (Uttarakhand, India) - A cross-sectional hospital-based study.J Family Med Prim Care. 2020 Mar 26;9(3):1362-1369. doi: 10.4103/jfmpc.jfmpc_1174_19. eCollection 2020 Mar. J Family Med Prim Care. 2020. PMID: 32509616 Free PMC article.
-
Case report: Expansion of visceral leishmaniasis to the western hilly part of Nepal.Am J Trop Med Hyg. 2011 Jan;84(1):107-8. doi: 10.4269/ajtmh.2011.10-0291. Am J Trop Med Hyg. 2011. PMID: 21212211 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources